TY - JOUR
T1 - Perforated meckel's diverticulitis and an ileal ulcer in rheumatoid arthritis
T2 - The pathogenic role of arterial thrombosis in these lesions
AU - Nakabayashi, Kimimasa
AU - Fujiwara, Masachika
AU - Nose, Masato
AU - Matsuki, Ryota
AU - Ohkura, Yasuo
AU - Kamma, Hiroshi
AU - Sugiyama, Masanori
AU - Sumiishi, Ayumi
PY - 2015
Y1 - 2015
N2 - Gastrointestinal (GI) tract perforation is a serious complication in patients with rheumatoid arthritis (RA). This complication has been reported in the eras of both disease-modifying anti-rheumatic drugs (DMARDs) and biologics for RA. However,the etiopathogenesis of this condition has not been satisfactorily clarified to date. We experienced the case of an 83-year-old male treated with adalimumab,methotrexate(MTX)and prednisolone(PSL) who developed hematochezia. The operation demonstrated perforated Meckel's diverticulitis and an ileal ulcer; these complications occurred after the interruption of RA treatment for eight weeks. The pathology showed an artery with organized thrombi in the diverticular wall associated with recanalization and a fresh thrombotic arteriole beneath the ileal ulcer, although there was no evidence of arteriosclerosis, angiitis, amyloidosis or infection. The former site of arterial thrombosis was presumed to play an important role in the pathogenesis of perforated Meckel's diverticulitis and the ileal ulcer in this case. The onset of arterial thrombosis during or shortly after the discontinuation of biologic treatment has rarely been described. However, the potential for arterial thrombosis should thus be considered in patients receiving such treatment who present with perforation or ulcers of the GI tract.
AB - Gastrointestinal (GI) tract perforation is a serious complication in patients with rheumatoid arthritis (RA). This complication has been reported in the eras of both disease-modifying anti-rheumatic drugs (DMARDs) and biologics for RA. However,the etiopathogenesis of this condition has not been satisfactorily clarified to date. We experienced the case of an 83-year-old male treated with adalimumab,methotrexate(MTX)and prednisolone(PSL) who developed hematochezia. The operation demonstrated perforated Meckel's diverticulitis and an ileal ulcer; these complications occurred after the interruption of RA treatment for eight weeks. The pathology showed an artery with organized thrombi in the diverticular wall associated with recanalization and a fresh thrombotic arteriole beneath the ileal ulcer, although there was no evidence of arteriosclerosis, angiitis, amyloidosis or infection. The former site of arterial thrombosis was presumed to play an important role in the pathogenesis of perforated Meckel's diverticulitis and the ileal ulcer in this case. The onset of arterial thrombosis during or shortly after the discontinuation of biologic treatment has rarely been described. However, the potential for arterial thrombosis should thus be considered in patients receiving such treatment who present with perforation or ulcers of the GI tract.
KW - Adalimumab
KW - Arterial thrombosis
KW - Ileal ulcer
KW - Perforated diverticulitis
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=84928539754&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928539754&partnerID=8YFLogxK
U2 - 10.2974/kmj.65.61
DO - 10.2974/kmj.65.61
M3 - Article
AN - SCOPUS:84928539754
VL - 65
SP - 61
EP - 68
JO - Kitakanto Medical Journal
JF - Kitakanto Medical Journal
SN - 1343-2826
IS - 1
ER -